Abstract | PURPOSE OF REVIEW:
Takayasu arteritis remains a therapeutic challenge. In spite of current treatments, progression of vascular lesions is observed frequently. The purpose of this article is to describe advances in therapeutic strategies for Takayasu arteritis. RECENT FINDINGS: SUMMARY: In the future, greater therapeutic success may be achieved by addressing both the inflammatory and the myointimal proliferative components of Takayasu arteritis. New drugs that target intimal hyperplasia, as well as drug-eluting stents, deserve to be studied for possible utility as adjuncts to present treatments.
|
Authors | Patrick Liang, Gary S Hoffman |
Journal | Current opinion in rheumatology
(Curr Opin Rheumatol)
Vol. 17
Issue 1
Pg. 16-24
(Jan 2005)
ISSN: 1040-8711 [Print] United States |
PMID | 15604900
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Topics |
- Combined Modality Therapy
- Drug Therapy, Combination
- Humans
- Rheumatology
(methods)
- Takayasu Arteritis
(drug therapy, surgery)
|